TJP Labs, a subsidiary of KIK ASS Products, has recently filed for a patent to safeguard their groundbreaking nicotine particulate technology that expedites the release of nicotine. This revolutionary product is designed to release nicotine at a much faster rate than polacrilex, a resin complex commonly found in nicotine replacement therapy products.
Some of the remarkable features of this innovative technology include the ability to customize particle size, precision-targeted binding for enhanced release rates, a broad range of core materials, efficient raw material usage, and an eco-friendly composition. The product is optimized for versatility and adaptability, with the potential for multiple applications.
TJP Labs aims to simplify the manufacturing process to make it easier to incorporate the technology into various nicotine pouch formats and other related products. David Richmond-Peck, Chief Relationship Officer at TJP Labs, emphasized the company’s commitment to innovation and their dedication to meeting changing consumer preferences.
TJP Labs specializes in developing cutting-edge products for modern oral nicotine consumption. The company anticipates having preliminary evaluation data available by the end of the second quarter of 2024. Their focus on innovation and intellectual property protection underscores their determination to lead in redefining nicotine consumption.
